Alternate brands of REVOLADE -

Alternate brands of REVOLADE - revolade Revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia lasting 6 months or longer from revolade Revolade is indicated in adult patients with chronic hepatitis C virus infection for the treatment of thrombocytopenia, where the degree of

revolade Product name: REVOLADE Company name: NOVARTIS PHARMACEUTICALS CANADA INC DIN: 02361825 Status: Marketed Status date: Filter items

revolade Revolade is the first approved therapy in the EU for patients with severe aplastic anemia who have not responded to other treatments The use of REVOLADE in adults to increase and maintain the platelet count prior to and throughout antiviral treatment of HCV infection gives patients a better